Cargando…
The Decline of Deep Brain Stimulation for Obsessive–Compulsive Disorder Following FDA Humanitarian Device Exemption Approval
Background: In February 2009, the US Food and Drug Administration (FDA) granted Humanitarian Device Exemption (HDE) for deep brain stimulation (DBS) in the anterior limb of the internal capsule (ALIC) for the treatment of severely debilitating, treatment refractory obsessive–compulsive disorder (OCD...
Autores principales: | Pinckard-Dover, Heather, Ward, Herbert, Foote, Kelly D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994854/ https://www.ncbi.nlm.nih.gov/pubmed/33777998 http://dx.doi.org/10.3389/fsurg.2021.642503 |
Ejemplares similares
-
Deep Brain Stimulation for Obsessive-Compulsive Disorder: Real World Experience Post-FDA-Humanitarian Use Device Approval
por: Kahn, Lora, et al.
Publicado: (2021) -
Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process
por: Heneghan, Carl J, et al.
Publicado: (2017) -
Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016) -
Six-Nine Year Follow-Up of Deep Brain Stimulation for Obsessive-Compulsive Disorder
por: Fayad, Sarah M., et al.
Publicado: (2016) -
Deep brain stimulation for refractory obsessive-compulsive disorder: A review and analysis of the FDA MAUDE database
por: Porwal, Mokshal H., et al.
Publicado: (2022)